Spexis AG
Develops therapeutics for rare diseases, oncology, and antimicrobial resistance.
SPEX | SW
Overview
Corporate Details
- ISIN(s):
- CH0106213793
- LEI:
- 391200S8HJE1I96FIG04
- Country:
- Switzerland
- Address:
- Hegenheimermattweg 125, 4123 Allschwil
- Website:
- https://www.polyphor.com/
- Sector:
- Manufacturing
Description
Spexis AG is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for rare diseases and oncology. The company leverages its expertise in macrocycle technology to create novel drug candidates designed to address high unmet medical needs. Its pipeline is advanced through a strategy that includes in-house discovery, development, in-licensing, and the acquisition of promising molecules. The primary therapeutic areas of interest include rare diseases and cancer, with an additional focus on antimicrobial resistance.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-06 02:00 |
Spexis to host business update conference call on October 9, 2023
|
English | 5.4 KB | ||
| 2023-09-29 07:25 |
Spexis provides business update and announces financial results for the first h…
|
English | 21.8 KB | ||
| 2023-09-29 02:00 |
Spexis provides business update and announces financial results for the first h…
|
English | 19.5 KB | ||
| 2023-09-28 07:30 |
Spexis announces the appointment of Goncalo Bernardes, Ph.D., as acting Head of…
|
English | 9.2 KB | ||
| 2023-09-28 02:00 |
Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of…
|
English | 7.7 KB | ||
| 2023-08-15 07:25 |
Spexis announces USD $2.5 million capital commitment to support the upcoming Ph…
|
English | 7.8 KB | ||
| 2023-08-15 02:00 |
Spexis announces USD $2.5 million capital commitment to support the upcoming Ph…
|
English | 6.3 KB | ||
| 2023-06-30 07:15 |
Spexis announces engagement with Maxim Group LLC as M&A advisor to support eval…
|
English | 7.8 KB | ||
| 2023-06-30 02:00 |
Spexis announces engagement with Maxim Group LLC as M&A advisor to support eval…
|
English | 6.4 KB | ||
| 2023-06-26 17:31 |
Spexis announces the results of its Annual General Meeting 2023
|
English | 7.8 KB | ||
| 2023-06-26 02:00 |
Spexis announces the results of its Annual General Meeting 2023
|
English | 6.3 KB | ||
| 2023-06-07 07:30 |
Spexis announces the publication of promising results for a novel class of macr…
|
English | 12.7 KB | ||
| 2023-06-07 02:00 |
Spexis announces the publication of promising results for a novel class of macr…
|
English | 10.9 KB | ||
| 2023-05-30 07:15 |
Spexis provides business update and announces financial results for the full ye…
|
English | 18.3 KB | ||
| 2023-05-30 02:00 |
Spexis provides business update and announces financial results for the full ye…
|
English | 16.4 KB |
Automate Your Workflow. Get a real-time feed of all Spexis AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Spexis AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Spexis AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-21 | N/A | Executive member | Other | None | N/A |
Peer Companies
